NOV 04, 2015 8:32 AM PST

Neonates Exposed to HBV Have Stronger Immune Systems

WRITTEN BY: Kara Marker
Previously thought to create immunotolerance, scientists from the Agency for Science, Technology and Research in Singapore have discovered that neonatal exposure to hepatitis B virus (HBV) actually enhances maturation of the unborn human immune system.

Mouse models of neonatal HBV exposure showed babies born in a state of immune tolerance which allows HBV to persist as a chronic infection. However, after analyzing the umbilical cord blood of human neonates of HBV chronically infected mothers, the team from Singapore saw that the exposure actually triggered increased maturation and development of innate immune cells and Th1 lymphocytes. Being born equipped with an enhanced immune system allowed human babies to respond to unrelated pathogens better than babies who were not exposed to HPV in utero, a process known as trained immunity.  
 
Computer-generated image of HBV

HBV is transmitted by bodily fluids and can cause either acute or chronic liver infection (CDC). HBV is best prevented by getting vaccinated. 

The scientists from Singapore were able to make their discovery after noticing that human neonatal HBV vaccinations were highly successful, differentiating human cases of human neonatal HBV exposure from mouse models. In addition to finding more innate and adaptive immune cells in cord blood of HBV-exposed neonates, the researchers found an "alteration of the cytokine environment." The low levels of IL-10 and high levels of IL-12p40 and IFN-a2 induced by HBV exposure are believed to provide the newborns with trained immunity.

The process of trained immunity was first discovered in 2011 when scientists saw that plants and invertebrates, which lack an adaptive immune system, could still protect themselves against re-infection, even without the memory capabilities of T and B cells. Similarly, innate immune systems in vertebrates could provide some immunological memory independently of the adaptive immune system. Scientists called this capability "trained immunity" (Cell Host Microbe). 

The scientists from Singapore continue to look at the role of HBV infections in stimulating the immune system during different stages of childhood. 

"The ages between two to 12 years is a 'black box': it's not really clear what happens during this early stage of infection," said Dr. Michelle Hong.

Watch the following video to learn more about HBV pathology and therapy options.
 

Source: Nature Communications
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 11, 2021
Immunology
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
NOV 11, 2021
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how severa ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 06, 2021
Health & Medicine
Can Behavioral Science Strategies Improve Vaccination Rates?
DEC 06, 2021
Can Behavioral Science Strategies Improve Vaccination Rates?
Vaccines stimulate the immune system to defend us against serious infectious diseases. In addition, vaccination prevents ...
DEC 09, 2021
Immunology
Stopping the Spread of COVID by Chewing Gum?
DEC 09, 2021
Stopping the Spread of COVID by Chewing Gum?
Scientists have developed a special chewing gum that could reduce the risk of spreading SARS-CoV-2. The technology was d ...
DEC 27, 2021
Cancer
Improving Immunotherapy with a Novel Nanoparticle
DEC 27, 2021
Improving Immunotherapy with a Novel Nanoparticle
Malignant pleural effusion (MPE) occurs in cancer patients experiencing a buildup of fluid and tumor cells in the pleura ...
JAN 06, 2022
Cancer
Breakthrough COVID Cases Cause Concern for Cancer Patients
JAN 06, 2022
Breakthrough COVID Cases Cause Concern for Cancer Patients
As we enter the third year of the COVID-19 pandemic, we continue to learn more about the respiratory virus leading to a ...
Loading Comments...